SIGNIFICANCE OF HEART RHYTHM VARIABILITY IN RHEUMATOID ARTHRITIS

Por E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. L. Nasonov
Publicado em 2016-02-01

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observatio...

Por E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
Publicado em 2015-11-01

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

Por I. G. Kirillova, D. S. Novikova, T. V. Popkova, E. V. Udachkina, E. I. Markelova, A. A. Novikov, Yu. N. Gorbunova, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina
Publicado em 2018-07-01

PROGRESSION OF CAROTID ARTERY ATHEROSCLEROSIS DURING TREATMENT TO TARGET IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

Por E. V. Udachkina, D. S. Novikova, T. V. Popkova, I. G. Kirillova, E. I. Markelova, Yu. N. Gorbunova, D. E. Karateev, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina, S. I. Glukhova, A. V. Volkov
Publicado em 2018-09-01

TIME COURSE OF CHANGES IN BLOOD LIPID PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING TREAT-TO-TARGET ANTIRHEUMATIC THERAPY: ACCORDING TO 18-MONTH FOLLOW-UP FINDINGS

Por E. V. Udachkina, D. S. Novikova, T. V. Popkova, I. G. Kirillova, Yu. N. Gorbunova, E. I. Markelova, D. E. Karateev, E. L. Luchikhina, A. A. Novikov, E. N. Aleksandrova, N. V. Demidova, M. A. Kanonirova, G. V. Lukina, A. V. Volkov, E. L. Nasonov
Publicado em 2016-07-01